MedPath

The detection of focal liver lesions with contrast-enhanced ultrasound

Recruiting
Conditions
liver tumours
10019815
Registration Number
NL-OMON32981
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

Patients >18 years old, with at least one focal liver lesion identified but not completely characterized.

Exclusion Criteria

Patients who are critically ill or medically unstable, with previous hypersensitivity to contrast for ultrasound or MRI, left to right cardiac shunts, severe pulmonary hypertension, chronic obstructive pulmonary disease, unstable angina or dysrhythmias, and pregnant or nursing mothers.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To compare diagnostic efficacy of contrast-enhanced sonography to MRI in<br /><br>patients with focal liver lesions. The diagnostic criterion will be the ability<br /><br>to diagnose benign versus malignant focal liver lesions.<br /><br>Our overall aim is that CEUS will be incorporated as a diagnostic tool in<br /><br>protocol (-s) for focal liver lesions and in screening algorithms for<br /><br>metastatic liver disease. Both the time to diagnosis and costs per patient are<br /><br>expected to decrease.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>To perform a cost-effectiveness study. </p><br>
© Copyright 2025. All Rights Reserved by MedPath